Vol 8. Issue 21 / July 14, 2008

Scripps Florida Researchers Find New Clue to Alzheimer's Disease Progression - Research from the Wahlestedt lab suggests that non-coding RNA could become a target for potential diagnostic and therapeutic development.

Bi-Coastal Collaboration Uncovers Novel Activators of Key Cell Receptors - The new findings, made possible by the joint efforts of California and Florida scientists, could help identify therapeutic targets and optimize drug candidates.

Chris Liang Blazes a Trail - "Although Scripps Florida is young, we have effective drug-discovery capabilities," says Chris Liang, associate professor and scientific director of the Translational Research Institute.

Andrea Nold Wins Bristol-Myers Squibb Graduate Fellowship

Pick-Wei Lau Wins American Heart Association Fellowship

Disease-Causing Mutations Reveal Surprising Pattern

Research Unveils New Stabilizing and Signaling Properties of Cholesterol in Key Human Receptors

NIH Awards $20 Million CTSA Grant to Scripps Translational Science Institute

Scientists Find Seizure Drug Reverses Cellular Effects of Alcohol Addiction in Model

New Patent Covers Broad Class of Promising Chemical Reactions

Scripps Research Celebrates 16th Commencement

Connecting with the Science of the Synapse

Scientists Identify Protein Critical for Iron Absorption

New Study Finds T Cell Multiplication Unexpectedly Delayed After Infection

Fundamental Questions: An Interview with Albert Eschenmoser

Scientists Reveal Critical Structure from Ebola Virus - The breakthrough findings from the Ollmann Saphire lab point to targets for drugs and vaccines.